Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications
MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implicatio...
Gespeichert in:
Veröffentlicht in: | Clinical and translational gastroenterology 2021-10, Vol.12 (10), p.e00416-e00416 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e00416 |
---|---|
container_issue | 10 |
container_start_page | e00416 |
container_title | Clinical and translational gastroenterology |
container_volume | 12 |
creator | Moret-Tatay, Inés Cerrillo, Elena Hervás, David Iborra, Marisa Sáez-González, Esteban Forment, Javier Tortosa, Luis Nos, Pilar Gadea, Jose Beltrán, Belén |
description | MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications.
Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used.
Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year.
Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism. |
doi_str_mv | 10.14309/ctg.0000000000000416 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8547914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2769976248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</originalsourceid><addsrcrecordid>eNpdkV1vFCEUhidGY5u1P0EziRd6MxUYmAEvTJr1q0nVzVYT7wjLHGaoDKwwY-OF_126W5u1JCdAeM57OOctiqcYnWJaI_FKT_0pOlwUNw-KY4IZq2pOvz88OB8VJyld7SBEuBCPi6OaNoKhmh4Xfy63oK2xulw5lUZVfrI6hvXns_LS9l5Nc4RUWl-uInRWT9b3pfJduQze2DjeXJcxDP5FKt_aBCpBuQY9xwhew-tyHRzs-JWahtCDz3XOx62zWk02-PSkeGSUS3Byuy-Kb-_ffV1-rC6-fDhfnl1UmnLKKt4wlAM4JVQZ3Gw06TYb1DAOLeKmA6MI47URusOtUIRQAaxukVEZM6quF8Wbve523ozQafBTVE5uox1V_C2DsvL_F28H2YdfkjPaijzyRfHyViCGnzOkSY42aXBOeQhzkrl8Q3NJijL6_B56Feboc3uStI0QbUMozxTbU3naKUUwd5_BSO48ltljed_jnPfssJO7rH-OZoDugevgJojph5uvIcoBlJsGiXBLEBK0IohgfCNa5cCs_guJqbOk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2769976248</pqid></control><display><type>article</type><title>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Moret-Tatay, Inés ; Cerrillo, Elena ; Hervás, David ; Iborra, Marisa ; Sáez-González, Esteban ; Forment, Javier ; Tortosa, Luis ; Nos, Pilar ; Gadea, Jose ; Beltrán, Belén</creator><creatorcontrib>Moret-Tatay, Inés ; Cerrillo, Elena ; Hervás, David ; Iborra, Marisa ; Sáez-González, Esteban ; Forment, Javier ; Tortosa, Luis ; Nos, Pilar ; Gadea, Jose ; Beltrán, Belén</creatorcontrib><description>MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications.
Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used.
Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year.
Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.</description><identifier>ISSN: 2155-384X</identifier><identifier>EISSN: 2155-384X</identifier><identifier>DOI: 10.14309/ctg.0000000000000416</identifier><identifier>PMID: 34695034</identifier><language>eng</language><publisher>United States: Wolters Kluwer</publisher><subject>Adult ; Biomarkers ; Colonoscopy ; Colorectal surgery ; Crohn Disease - blood ; Crohn Disease - diagnostic imaging ; Crohn Disease - genetics ; Crohn Disease - surgery ; Crohn's disease ; Epigenetics ; Female ; Gene expression ; Health risks ; Humans ; Ileum - diagnostic imaging ; Inflammatory Bowel Disease ; Male ; MicroRNAs ; MicroRNAs - blood ; Middle Aged ; Nomograms ; Pathogenesis ; Postoperative period ; Reactive oxygen species ; Recurrence ; Risk Assessment ; Tumor necrosis factor-TNF ; Young Adult</subject><ispartof>Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00416-e00416</ispartof><rights>Wolters Kluwer</rights><rights>Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.</rights><rights>2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</citedby><cites>FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</cites><orcidid>0000-0003-2086-1521</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547914/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547914/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34695034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moret-Tatay, Inés</creatorcontrib><creatorcontrib>Cerrillo, Elena</creatorcontrib><creatorcontrib>Hervás, David</creatorcontrib><creatorcontrib>Iborra, Marisa</creatorcontrib><creatorcontrib>Sáez-González, Esteban</creatorcontrib><creatorcontrib>Forment, Javier</creatorcontrib><creatorcontrib>Tortosa, Luis</creatorcontrib><creatorcontrib>Nos, Pilar</creatorcontrib><creatorcontrib>Gadea, Jose</creatorcontrib><creatorcontrib>Beltrán, Belén</creatorcontrib><title>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</title><title>Clinical and translational gastroenterology</title><addtitle>Clin Transl Gastroenterol</addtitle><description>MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications.
Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used.
Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year.
Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.</description><subject>Adult</subject><subject>Biomarkers</subject><subject>Colonoscopy</subject><subject>Colorectal surgery</subject><subject>Crohn Disease - blood</subject><subject>Crohn Disease - diagnostic imaging</subject><subject>Crohn Disease - genetics</subject><subject>Crohn Disease - surgery</subject><subject>Crohn's disease</subject><subject>Epigenetics</subject><subject>Female</subject><subject>Gene expression</subject><subject>Health risks</subject><subject>Humans</subject><subject>Ileum - diagnostic imaging</subject><subject>Inflammatory Bowel Disease</subject><subject>Male</subject><subject>MicroRNAs</subject><subject>MicroRNAs - blood</subject><subject>Middle Aged</subject><subject>Nomograms</subject><subject>Pathogenesis</subject><subject>Postoperative period</subject><subject>Reactive oxygen species</subject><subject>Recurrence</subject><subject>Risk Assessment</subject><subject>Tumor necrosis factor-TNF</subject><subject>Young Adult</subject><issn>2155-384X</issn><issn>2155-384X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkV1vFCEUhidGY5u1P0EziRd6MxUYmAEvTJr1q0nVzVYT7wjLHGaoDKwwY-OF_126W5u1JCdAeM57OOctiqcYnWJaI_FKT_0pOlwUNw-KY4IZq2pOvz88OB8VJyld7SBEuBCPi6OaNoKhmh4Xfy63oK2xulw5lUZVfrI6hvXns_LS9l5Nc4RUWl-uInRWT9b3pfJduQze2DjeXJcxDP5FKt_aBCpBuQY9xwhew-tyHRzs-JWahtCDz3XOx62zWk02-PSkeGSUS3Byuy-Kb-_ffV1-rC6-fDhfnl1UmnLKKt4wlAM4JVQZ3Gw06TYb1DAOLeKmA6MI47URusOtUIRQAaxukVEZM6quF8Wbve523ozQafBTVE5uox1V_C2DsvL_F28H2YdfkjPaijzyRfHyViCGnzOkSY42aXBOeQhzkrl8Q3NJijL6_B56Feboc3uStI0QbUMozxTbU3naKUUwd5_BSO48ltljed_jnPfssJO7rH-OZoDugevgJojph5uvIcoBlJsGiXBLEBK0IohgfCNa5cCs_guJqbOk</recordid><startdate>20211025</startdate><enddate>20211025</enddate><creator>Moret-Tatay, Inés</creator><creator>Cerrillo, Elena</creator><creator>Hervás, David</creator><creator>Iborra, Marisa</creator><creator>Sáez-González, Esteban</creator><creator>Forment, Javier</creator><creator>Tortosa, Luis</creator><creator>Nos, Pilar</creator><creator>Gadea, Jose</creator><creator>Beltrán, Belén</creator><general>Wolters Kluwer</general><general>Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2086-1521</orcidid></search><sort><creationdate>20211025</creationdate><title>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</title><author>Moret-Tatay, Inés ; Cerrillo, Elena ; Hervás, David ; Iborra, Marisa ; Sáez-González, Esteban ; Forment, Javier ; Tortosa, Luis ; Nos, Pilar ; Gadea, Jose ; Beltrán, Belén</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4845-8650865e8424af16bc2dbb0658e708fdefa2583f9cd179a2249e5370fadbbfa33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Biomarkers</topic><topic>Colonoscopy</topic><topic>Colorectal surgery</topic><topic>Crohn Disease - blood</topic><topic>Crohn Disease - diagnostic imaging</topic><topic>Crohn Disease - genetics</topic><topic>Crohn Disease - surgery</topic><topic>Crohn's disease</topic><topic>Epigenetics</topic><topic>Female</topic><topic>Gene expression</topic><topic>Health risks</topic><topic>Humans</topic><topic>Ileum - diagnostic imaging</topic><topic>Inflammatory Bowel Disease</topic><topic>Male</topic><topic>MicroRNAs</topic><topic>MicroRNAs - blood</topic><topic>Middle Aged</topic><topic>Nomograms</topic><topic>Pathogenesis</topic><topic>Postoperative period</topic><topic>Reactive oxygen species</topic><topic>Recurrence</topic><topic>Risk Assessment</topic><topic>Tumor necrosis factor-TNF</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moret-Tatay, Inés</creatorcontrib><creatorcontrib>Cerrillo, Elena</creatorcontrib><creatorcontrib>Hervás, David</creatorcontrib><creatorcontrib>Iborra, Marisa</creatorcontrib><creatorcontrib>Sáez-González, Esteban</creatorcontrib><creatorcontrib>Forment, Javier</creatorcontrib><creatorcontrib>Tortosa, Luis</creatorcontrib><creatorcontrib>Nos, Pilar</creatorcontrib><creatorcontrib>Gadea, Jose</creatorcontrib><creatorcontrib>Beltrán, Belén</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and translational gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moret-Tatay, Inés</au><au>Cerrillo, Elena</au><au>Hervás, David</au><au>Iborra, Marisa</au><au>Sáez-González, Esteban</au><au>Forment, Javier</au><au>Tortosa, Luis</au><au>Nos, Pilar</au><au>Gadea, Jose</au><au>Beltrán, Belén</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications</atitle><jtitle>Clinical and translational gastroenterology</jtitle><addtitle>Clin Transl Gastroenterol</addtitle><date>2021-10-25</date><risdate>2021</risdate><volume>12</volume><issue>10</issue><spage>e00416</spage><epage>e00416</epage><pages>e00416-e00416</pages><issn>2155-384X</issn><eissn>2155-384X</eissn><abstract>MicroRNAs (miRNAs) are important epigenetic regulators in Crohn's disease (CD); however, their contribution to postoperative recurrence (POR) is still unknown. We aimed to characterize the potential role of miRNAs in predicting POR in patients with CD and to identify their pathogenic implications.
Of 67 consecutively operated patients with CD, we included 44 with pure ileal CD. Peripheral blood samples were taken before surgery and during follow-up. The patients were classified according to the presence or absence of POR assessed by ileocolonoscopy or magnetic resonance imaging enterography. The miRNAs were profiled by reverse transcription polymerase chain reaction before surgery and during morphological POR or, for those who remained in remission, 1 year after surgery. R software and mirWalk were used.
Five human miRNAs (miR-191-5p, miR-15b-5p, miR-106b-5p, miR-451a, and miR-93-5p) were selected for discriminating between the 2 patient groups at presurgery (PS), with an area under the curve of 0.88 (95% confidence interval [0.79, 0.98]). Another 5 (miR-15b-5p, miR-451a, miR-93-5p, miR-423-5p, and miR-125b-5p) were selected for 1 year, with an area under the curve of 0.96 (95% confidence interval [0.91, 1.0]). We also created nomograms for POR risk estimation. CCND2 and BCL9L genes were related to PS miRNA profiles; SENP5 and AKT3 genes were related to PS and 1 year; and SUV39H1 and MAPK3K10 were related to 1 year.
Different plasma miRNA signatures identify patients at high POR risk, which could help optimize patient outcomes. We developed nomograms to facilitate the clinical use of these results. The identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.</abstract><cop>United States</cop><pub>Wolters Kluwer</pub><pmid>34695034</pmid><doi>10.14309/ctg.0000000000000416</doi><orcidid>https://orcid.org/0000-0003-2086-1521</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2155-384X |
ispartof | Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00416-e00416 |
issn | 2155-384X 2155-384X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8547914 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Adult Biomarkers Colonoscopy Colorectal surgery Crohn Disease - blood Crohn Disease - diagnostic imaging Crohn Disease - genetics Crohn Disease - surgery Crohn's disease Epigenetics Female Gene expression Health risks Humans Ileum - diagnostic imaging Inflammatory Bowel Disease Male MicroRNAs MicroRNAs - blood Middle Aged Nomograms Pathogenesis Postoperative period Reactive oxygen species Recurrence Risk Assessment Tumor necrosis factor-TNF Young Adult |
title | Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T01%3A12%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20Plasma%20MicroRNA%20Signatures%20in%20Predicting%20and%20Confirming%20Crohn's%20Disease%20Recurrence:%20Role%20and%20Pathogenic%20Implications&rft.jtitle=Clinical%20and%20translational%20gastroenterology&rft.au=Moret-Tatay,%20In%C3%A9s&rft.date=2021-10-25&rft.volume=12&rft.issue=10&rft.spage=e00416&rft.epage=e00416&rft.pages=e00416-e00416&rft.issn=2155-384X&rft.eissn=2155-384X&rft_id=info:doi/10.14309/ctg.0000000000000416&rft_dat=%3Cproquest_pubme%3E2769976248%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2769976248&rft_id=info:pmid/34695034&rfr_iscdi=true |